REFERENCES
- Bhat, R., & Steinman, L. (2009). Innate and adaptive autoimmunity directed to the central nervous system. Neuron, 64(1), 123–132.
- Darnell, R. B., & Posner, J. B. (2006). Paraneoplastic syndromes affecting the nerve system. Seminars in Oncology, 33(3), 270–298.
- Endsley, M. A., Njongmeta, L. M., Shell, E., Ryan, M. W., Indrikovs, A. J., Ulualp, S., (2009). Human IgA-inducing protein from dendritic cells induces IgA production by naive IgD+ B cells. Journal of Immunology, 182(4), 1854–1859.
- Graus, F., Delattre, J. Y., Antoine, J. C., Dalmau, J., Giometto, B., Grisold, W., (2004). Recommended diagnostic criteria for paraneoplastic neurological syndromes. Journal of Neurology, Neurosurgery, and Psychiatry, 75(8), 1135–1140.
- Huynh, H., Cordato, D. J., Kehdi, E., Masters, L. T., & Dedousis, C. (2008). Post-vaccination encephalomyelitis: Literature review and illustrative case. Journal of Clinical Neuroscience, 15(12), 1315–1322.
- Izurieta, H. S., Haber, P., Wise, R. P., Iskander, J., Pratt, D., Mink, C., (2005). Adverse events reported following live, cold adapted, intranasal influenza vaccine. Journal of the American Medical Association, 294(21), 2720–2725.
- Nakamura, N., Nokura, K., Zettsu, T., Koga, H., Tachi, M., Terada, M., (2003). Neurologic complications associated with influenza vaccination: Two adult cases. Internal Medicine, 42(2), 191–194.
- Nakayama, T., & Onoda, K. (2007). Vaccine adverse events reported in postmarketing study of the Kitasato Institute from 1994 to 2004. Vaccine, 25(3), 570–576.
- Pearce, C. N., O’Laughlin, J. L., & Hayney, M. S. (2008). Optimal cancer management includes influenza vaccination. Journal of the American Pharmacists Association, 48(6), 813–814.
- Pou, M. A., Diaz-Torne, C., Vidal, S., Corchero, C., Narvaez, J., Nolla, J. M., (2008). Development of autoimmune diseases after vaccination. Journal of Clinical Rheumatology, 14(4), 243–244.